Elite Pharmaceuticals Statistics
Total Valuation
ELTP has a market cap or net worth of 470.04 million. The enterprise value is 473.02 million.
| Market Cap | 470.04M |
| Enterprise Value | 473.02M |
Important Dates
The next estimated earnings date is Friday, June 27, 2025.
| Earnings Date | Jun 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ELTP has 1.07 billion shares outstanding. The number of shares has increased by 3.71% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.07B |
| Shares Change (YoY) | +3.71% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 22.21% |
| Owned by Institutions (%) | n/a |
| Float | 831.02M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.64 |
| PB Ratio | 12.90 |
| P/TBV Ratio | 13.00 |
| P/FCF Ratio | 108.91 |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 32.81, with an EV/FCF ratio of 109.60.
| EV / Earnings | -26.30 |
| EV / Sales | 6.76 |
| EV / EBITDA | 32.81 |
| EV / EBIT | 38.85 |
| EV / FCF | 109.60 |
Financial Position
The company has a current ratio of 3.27, with a Debt / Equity ratio of 0.31.
| Current Ratio | 3.27 |
| Quick Ratio | 1.82 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | 0.78 |
| Debt / FCF | 2.61 |
| Interest Coverage | 15.21 |
Financial Efficiency
Return on equity (ROE) is -43.41% and return on invested capital (ROIC) is 14.92%.
| Return on Equity (ROE) | -43.41% |
| Return on Assets (ROA) | 9.20% |
| Return on Invested Capital (ROIC) | 14.92% |
| Return on Capital Employed (ROCE) | 16.01% |
| Revenue Per Employee | 1.09M |
| Profits Per Employee | -281,040 |
| Employee Count | 64 |
| Asset Turnover | 0.85 |
| Inventory Turnover | 2.27 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +187.58% in the last 52 weeks. The beta is 0.14, so ELTP's price volatility has been lower than the market average.
| Beta (5Y) | 0.14 |
| 52-Week Price Change | +187.58% |
| 50-Day Moving Average | 0.49 |
| 200-Day Moving Average | 0.41 |
| Relative Strength Index (RSI) | 33.53 |
| Average Volume (20 Days) | 557,294 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.06 |
Income Statement
In the last 12 months, ELTP had revenue of 70.00 million and -17.99 million in losses. Loss per share was -0.02.
| Revenue | 70.00M |
| Gross Profit | 30.91M |
| Operating Income | 12.18M |
| Pretax Income | -17.33M |
| Net Income | -17.99M |
| EBITDA | 13.78M |
| EBIT | 12.18M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 8.29 million in cash and 11.28 million in debt, giving a net cash position of -2.98 million or -0.00 per share.
| Cash & Cash Equivalents | 8.29M |
| Total Debt | 11.28M |
| Net Cash | -2.98M |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | 36.45M |
| Book Value Per Share | 0.03 |
| Working Capital | 33.36M |
Cash Flow
In the last 12 months, operating cash flow was 5.59 million and capital expenditures -1.27 million, giving a free cash flow of 4.32 million.
| Operating Cash Flow | 5.59M |
| Capital Expenditures | -1.27M |
| Free Cash Flow | 4.32M |
| FCF Per Share | 0.00 |
Margins
Gross margin is 44.16%, with operating and profit margins of 17.39% and -25.70%.
| Gross Margin | 44.16% |
| Operating Margin | 17.39% |
| Pretax Margin | -24.76% |
| Profit Margin | -25.70% |
| EBITDA Margin | 19.68% |
| EBIT Margin | 17.39% |
| FCF Margin | 6.17% |
Dividends & Yields
ELTP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.71% |
| Shareholder Yield | -3.71% |
| Earnings Yield | -3.83% |
| FCF Yield | 0.92% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ELTP has an Altman Z-Score of 2.78. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.78 |
| Piotroski F-Score | n/a |